(Q38049753)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040353%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Oral manifestations of systemic autoimmune and inflammatory diseases: diagnosis and clinical management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040353%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040353%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

3

Niki M Moutsopoulos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040353%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

2

Mojgan Sarmadi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040353%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

1 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040353%20AND%20SRC:MED&resulttype=core&format=json

Journal of Evidence-Based Dental Practice

9 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040353%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040353%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

265-282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040353%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

3 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040353%20AND%20SRC:MED&resulttype=core&format=json

Mucosal disease series. Number VI. Recurrent aphthous stomatitis

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Urban legends: recurrent aphthous stomatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Biologics in oral medicine: ulcerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Recurrent aphthous stomatitis in Rheumatology

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Recurrent aphthous stomatitis. A study of the clinical characteristics of lesions in 93 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Epidemiologic studies of oral mucosal conditions - methodologic issues

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Biopsy techniques and diagnoses & treatment of mucocutaneous lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

A comparative study of the efficacy of Aphtheal in the management of recurrent minor aphthous ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Periodic fever syndrome in children

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Periodic fever syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Clinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Risk indicators for recurrent aphthous ulcers among adults in the US

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Epidemiology of oral mucosal lesions in United States schoolchildren: 1986-87.

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Epidemiologic aspects of recurrent aphthous ulcerations

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Comparison of the clinical features of recurrent aphthous stomatitis and Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Defining a T-cell epitope within HSP 65 in recurrent aphthous stomatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

IL-1B and IL-6 gene polymorphisms encode significant risk for the development of recurrent aphthous stomatitis (RAS).

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Effectiveness of vitamin B12 in treating recurrent aphthous stomatitis: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Topical immunomodulators for management of oral mucosal conditions, a systematic review; Part II: miscellaneous agents

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Refractory aphthous ulceration treated with thalidomide: a report of 10 years' clinical experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Efficacy of tumour necrosis factor-α antagonists in aphthous ulceration: review of published individual patient data.

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Etiopathogenesis of Behcet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

How to deal with Behcet's disease in daily practice

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Behçet's disease (Adamantiades-Behçet's disease).

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

The close association between dental and periodontal treatments and oral ulcer course in behcet's disease: a prospective clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

The Crohn's disease susceptibility gene DLG5 as a member of the CARD interaction network

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Role of genetics in the diagnosis and prognosis of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

A prospective study of the oral manifestations of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

The oral cavity in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Thalidomide for the treatment of oral aphthous ulcers in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Advances in graft-versus-host disease biology and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Oral graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

"Secondary disease" of radiation chimeras: a syndrome due to lymphoid aplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Chronic graft versus host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Wo

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Oral chronic graft-vs.-host disease characterization using the NIH scale.

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Weight loss and malnutrition in patients with chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Pilocarpine hydrochloride for symptomatic relief of xerostomia due to chronic graft-versus-host disease or total-body irradiation after bone-marrow transplantation for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Autoimmune oral mucosal diseases: clinical, etiologic, diagnostic, and treatment considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Oral involvement in autoimmune bullous diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

The geoepidemiology of Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Therapy of Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

The management of Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Topical and systemic medications for the treatment of primary Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Clinically relevant information about cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Review of literature for the striking clinic picture seen in two infants of mothers with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Oral manifestations of lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Belimumab for the management of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Oral manifestations of systemic and cutaneous lupus erythematosus in a Venezuelan population

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Gastrointestinal manifestations of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Environment and lupus-related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Mechanisms of B cell autoimmunity in SLE.

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Oral ulcers: clinical aspects. A tool for dermatologists. Part II. Chronic ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Squamous cell carcinoma on the palate in a patient with systemic lupus erythematosus: case report and review of literature

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Squamous cell carcinoma complicating discoid lupus erythematosus in Chinese patients: review of the literature, 1964-2010.

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Tacrolimus ointment: the treatment of atopic dermatitis and other inflammatory cutaneous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Treatment of discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Methotrexate and oral ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Avascular necrosis of the metacarpal head: a report of two cases and review of literature

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

The epidemiology of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

The pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Temporomandibular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Periodontitis in systemic rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Serum antibodies and loss of periodontal bone in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Risk for periodontal disease in patients with longstanding rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Is there a relationship between rheumatoid arthritis and periodontal disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Relationship between rheumatoid arthritis and periodontitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Periodontal disease and rheumatoid arthritis: is there a link?

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Rheumatoid arthritis, periodontal disease and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Some predictors of radiographic alveolar bone height reduction over 6 years

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Risk indicators for tooth loss due to periodontal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Association Among Rheumatoid Arthritis, Oral Hygiene, and Periodontitis

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

Periodontal and hematological characteristics associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

The association between rheumatoid arthritis and periodontal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1532-3382%2812%2970051-9

7 January 2021

10.1016/S1532-3382(12)70051-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23040353%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference